Dimensional Fund Advisors LP Boosts Stock Position in The Clorox Company (NYSE:CLX)

Dimensional Fund Advisors LP lifted its position in shares of The Clorox Company (NYSE:CLX) by 11.9% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 802,237 shares of the company’s stock after purchasing an additional 85,529 shares during the period. Dimensional Fund Advisors LP owned 0.65% of Clorox worth $109,483,000 as of its most recent SEC filing.

A number of other institutional investors also recently modified their holdings of CLX. Core Wealth Advisors Inc. purchased a new stake in shares of Clorox during the fourth quarter worth about $29,000. Innealta Capital LLC bought a new position in Clorox in the second quarter worth about $30,000. Trifecta Capital Advisors LLC raised its stake in Clorox by 139.8% in the second quarter. Trifecta Capital Advisors LLC now owns 223 shares of the company’s stock worth $30,000 after buying an additional 130 shares in the last quarter. GoalVest Advisory LLC bought a new position in Clorox in the first quarter worth about $31,000. Finally, First Foundation Advisors bought a new position in Clorox in the first quarter worth about $31,000. 78.53% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity

In other news, EVP Angela C. Hilt sold 1,733 shares of the business’s stock in a transaction on Friday, September 6th. The shares were sold at an average price of $165.52, for a total transaction of $286,846.16. Following the completion of the sale, the executive vice president now owns 13,471 shares of the company’s stock, valued at approximately $2,229,719.92. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Insiders own 0.51% of the company’s stock.

Clorox Trading Up 0.9 %

NYSE:CLX opened at $164.84 on Tuesday. The company has a current ratio of 1.03, a quick ratio of 0.63 and a debt-to-equity ratio of 5.04. The Clorox Company has a 12 month low of $114.68 and a 12 month high of $169.09. The company has a market cap of $20.47 billion, a PE ratio of 85.41, a price-to-earnings-growth ratio of 3.29 and a beta of 0.40. The company has a 50 day simple moving average of $149.75 and a two-hundred day simple moving average of $143.76.

Clorox (NYSE:CLX) last posted its earnings results on Thursday, August 1st. The company reported $1.82 EPS for the quarter, topping analysts’ consensus estimates of $1.54 by $0.28. Clorox had a net margin of 3.95% and a return on equity of 281.12%. The business had revenue of $1.90 billion during the quarter, compared to the consensus estimate of $1.97 billion. Research analysts forecast that The Clorox Company will post 6.63 earnings per share for the current year.

Clorox Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, November 7th. Stockholders of record on Wednesday, October 23rd will be given a dividend of $1.22 per share. This represents a $4.88 dividend on an annualized basis and a dividend yield of 2.96%. The ex-dividend date of this dividend is Wednesday, October 23rd. Clorox’s payout ratio is 252.85%.

Analyst Upgrades and Downgrades

A number of research firms recently issued reports on CLX. Deutsche Bank Aktiengesellschaft increased their price target on shares of Clorox from $144.00 to $151.00 and gave the stock a “hold” rating in a research note on Friday, August 2nd. Argus raised shares of Clorox to a “hold” rating in a research note on Tuesday, June 4th. TD Cowen started coverage on shares of Clorox in a research note on Tuesday, July 23rd. They set a “sell” rating and a $122.00 target price for the company. Wells Fargo & Company decreased their target price on shares of Clorox from $135.00 to $130.00 and set an “underweight” rating for the company in a research note on Wednesday, July 10th. Finally, BNP Paribas raised shares of Clorox to a “strong sell” rating in a research note on Friday, September 6th. Six equities research analysts have rated the stock with a sell rating and twelve have assigned a hold rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $143.33.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.